Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Schembl21062649
2. Sbt-272
3. (r)-2-amino-n-((s)-1-(((s)-5-amino-1-(3-benzyl-1,2,4-oxadiazol-5-yl)pentyl)amino)-3-(4-hydroxy-2,6-dimethylphenyl)-1-oxopropan-2-yl)-5-guanidinopentanamide
4. 2356106-71-1
5. L-tyrosinamide, D-arginyl-n-[(1s)-5-amino-1-[3-(phenylmethyl)-1,2,4-oxadiazol-5-yl]pentyl]-2,6-dimethyl-
| Molecular Weight | 607.7 g/mol |
|---|---|
| Molecular Formula | C31H45N9O4 |
| XLogP3 | 1.4 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 17 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 234 |
| Heavy Atom Count | 44 |
| Formal Charge | 0 |
| Complexity | 887 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
12
PharmaCompass offers a list of SBT-272 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right SBT-272 manufacturer or SBT-272 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred SBT-272 manufacturer or SBT-272 supplier.
PharmaCompass also assists you with knowing the SBT-272 API Price utilized in the formulation of products. SBT-272 API Price is not always fixed or binding as the SBT-272 Price is obtained through a variety of data sources. The SBT-272 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A SBT-272 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of SBT-272, including repackagers and relabelers. The FDA regulates SBT-272 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. SBT-272 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A SBT-272 supplier is an individual or a company that provides SBT-272 active pharmaceutical ingredient (API) or SBT-272 finished formulations upon request. The SBT-272 suppliers may include SBT-272 API manufacturers, exporters, distributors and traders.
SBT-272 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of SBT-272 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right SBT-272 GMP manufacturer or SBT-272 GMP API supplier for your needs.
A SBT-272 CoA (Certificate of Analysis) is a formal document that attests to SBT-272's compliance with SBT-272 specifications and serves as a tool for batch-level quality control.
SBT-272 CoA mostly includes findings from lab analyses of a specific batch. For each SBT-272 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
SBT-272 may be tested according to a variety of international standards, such as European Pharmacopoeia (SBT-272 EP), SBT-272 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (SBT-272 USP).
